N,N-DIPROPYLTRYPTAMINE

Basic information

  • Product Name:N,N-DIPROPYLTRYPTAMINE
  • CasNo.:61-52-9
  • MF:C16H24N2
  • MW:244.38

Physical and Chemical Properties

  • Purity:99%
  • Boiling Point:174-178 °C
  • Packing:
  • Throughput:
Inquiry

Product Details

CasNo: 61-52-9

MF: C16H24N2

Chinese Manufacturer Supply Best Quality 61-52-9 N,N-DIPROPYLTRYPTAMINE with Efficient Delivery

  • Molecular Formula:C16H24N2
  • Molecular Weight:244.38
  • Vapor Pressure:3.3E-06mmHg at 25°C 
  • Melting Point:174-178 °C 
  • Refractive Index:1.574 
  • Boiling Point:387.4 °C at 760 mmHg 
  • PKA:17.30±0.30(Predicted) 
  • Flash Point:188.1 °C 
  • PSA:19.03000 
  • Density:1.014 g/cm3 
  • LogP:3.83240 

N,N-DIPROPYLTRYPTAMINE(Cas 61-52-9) Usage

N,N-dipropyltryptamine (DPT) is a synthetic tryptamine hallucinogen which has been used psychotherapeutically in humans. The Psychedelic N,N-Dipropyltryptamine Prevents Seizures in a Mouse Model of Fragile X Syndrome via a Mechanism that Appears Independent of Serotonin and Sigma1 Receptors.

InChI:InChI=1/C16H24N2/c1-3-10-18(11-4-2)12-9-14-13-17-16-8-6-5-7-15(14)16/h5-8,13,17H,3-4,9-12H2,1-2H3

61-52-9 Relevant articles

Binding properties of dipropyltryptamine at the human 5-HT1a receptor

Thiagaraj, Harish V.,Russo, Ethan B.,Burnett, Andrea,Goldstein, Eric,Thompson, Charles M.,Parker, Keith K.

, p. 193 - 199 (2005)

Dipropyltryptamine (DPT) is a synthetic ...

Hallucinogen-like effects of N,N-dipropyltryptamine (DPT): Possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents

William E. Fantegrossi a , Chad J. Reissig b , Elyse B. Katz a , Haley L. Yarosh a , Kenner C. Rice c , Jerrold C. Winter b

Pharmacology Biochemistry and Behavior Volume 88, Issue 3 , January 2008, Pages 358-365

In the present studies, DPT was tested in a drug-elicited head-twitch assay in mice, and in rats trained to discriminate lysergic acid diethylamide (LSD), N,N-dimethyl-4-phosphoryloxytryptamine (psilocybin), or 3,4-methylenedioxymethamphetamine (MDMA). A separate group of rats was also trained to recognize DPT itself as a discriminative stimulus, and in all cases, the behavioral effects of DPT were challenged with the selective serotonin (5-HT)2A antagonist M100907, the 5-HT1A selective antagonist WAY-100635, or their combination.

The Psychedelic N,N-Dipropyltryptamine Prevents Seizures in a Mouse Model of Fragile X Syndrome via a Mechanism that Appears Independent of Serotonin and Sigma1 Receptors

Richa TyagiTanishka S. SarafClinton E. Canal*

ACS Pharmacol. Transl. Sci. 2023, 6, 10, 1480–1491

We show that a similar psychedelic tryptamine, N,N-dipropyltryptamine (DPT), completely prevents audiogenic seizures (AGS) in an Fmr1 knockout mouse model of fragile X syndrome at a 10 mg/kg dose but not at lower doses (3 or 5.6 mg/kg). Despite showing in vitro that DPT is a serotonin 5-HT2A, 5-HT1B, and 5-HT1A receptor agonist (with that rank order of functional potency, determined with TRUPATH Gα/βγ biosensors), pretreatment with selective inhibitors of 5-HT2A/2C, 5-HT1B, or 5-HT1A receptors did not block DPT’s antiepileptic effects; a pan-serotonin receptor antagonist was also ineffective.

61-52-9 Process route

tryptamine
61-54-1

tryptamine

propionaldehyde
123-38-6

propionaldehyde

Dipropyltryptamine
61-52-9

Dipropyltryptamine

Conditions
Conditions Yield
With sodium cyanoborohydride; acetic acid; In methanol; at 0 - 20 ℃; Inert atmosphere;
94%
tryptamine
61-54-1

tryptamine

1-iodo-propane
107-08-4

1-iodo-propane

N-ethyl-N,N-diisopropylamine
7087-68-5

N-ethyl-N,N-diisopropylamine

Dipropyltryptamine
61-52-9

Dipropyltryptamine

Conditions
Conditions Yield
In diethyl ether; at 20 ℃; for 16h;
46%

61-52-9 Upstream products

  • 3389-21-7
    3389-21-7

    3-(2-bromoethyl)-1H-indole

  • 142-84-7
    142-84-7

    di-n-propylamine

  • 61-54-1
    61-54-1

    tryptamine

  • 107-08-4
    107-08-4

    1-iodo-propane